SSC
GILD icon

Syverson Strege & Co’s Gilead Sciences GILD Stock Holding History

Syverson Strege & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$422K Buy
3,341
+133
+4% +$17.5K 0.09% 97
2026
Q1 		$447K Buy
3,208
+103
+3% +$14.4K 0.11% 85
2025
Q4 		$381K Buy
3,105
+436
+16% +$53K 0.09% 94
2025
Q3 		$296K Sell
2,669
-284
-10% -$32.3K 0.07% 116
2025
Q2 		$327K Buy
+2,953
New +$314K 0.08% 108
2023
Q2 		– Sell
-110
Closed -$9.13K – 284
2023
Q1 		$9.13K Buy
+110
New +$9.11K ﹤0.01% 262

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Syverson Strege & Co's GILD Position: Q2 2026 in Review

Syverson Strege & Co increased its Gilead Sciences (GILD) stake by 4.1% in Q2 2026, buying an estimated $17.5K and bringing the position to 3,341 shares worth $422K. The position accounts for 0.09% of the portfolio, ranked #97.

Syverson Strege & Co first reported a position in GILD in Q1 2023 and has held it in 6 quarters since. The position peaked at $447K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Syverson Strege & Co held 3,341 shares of Gilead Sciences worth $422K as of Q2 2026.
  • Syverson Strege & Co bought 133 Gilead Sciences shares in Q2 2026, an estimated $17.5K.
  • Gilead Sciences made up 0.09% of Syverson Strege & Co's portfolio in Q2 2026, its #97 holding.
  • Syverson Strege & Co first reported a position in Gilead Sciences in Q1 2023 and has held it in 6 quarters since.
  • Syverson Strege & Co's Gilead Sciences position peaked at $447K in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Syverson Strege & Co's 13F filing for Q2 2026, filed 6 Aug 2026.